PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
190.98%
Some net income increase while VET is negative at -15.00%. John Neff would see a short-term edge over the struggling competitor.
-0.24%
Both reduce yoy D&A, with VET at -2.23%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
833.18%
Well above VET's 121.88% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
127.87%
Less working capital growth vs. VET's 778.31%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
127.87%
Lower 'other working capital' growth vs. VET's 778.31%. David Dodd would see fewer unexpected short-term demands on cash.
-991.38%
Negative yoy while VET is 132.34%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
53.13%
Some CFO growth while VET is negative at -8.65%. John Neff would note a short-term liquidity lead over the competitor.
-23.48%
Both yoy lines negative, with VET at -19.58%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
451.91%
We have some outflow growth while VET is negative at -31.66%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-14.19%
Both yoy lines negative, with VET at -21.60%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while VET is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-84.66%
Both yoy lines negative, with VET at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
100.00%
Buyback growth of 100.00% while VET is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.